Overview

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Status:
Unknown status
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
To test the therapeutic ratio of additional chemotheray on advanced nasopharyngeal carcinoma.
Phase:
N/A
Details
Lead Sponsor:
Hospital Authority, Hong Kong
Collaborator:
Hong Kong Nasopharyngeal Cancer Study Group Limited
Treatments:
Fluorouracil